Stock 4737 BIONIME CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bionime Corporation

Equities

4737

TW0004737002

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
68.8 TWD -0.58% Intraday chart for Bionime Corporation -0.15% -8.02%
Mar. 15 Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 14 Bionime Corporation Announces Dividend for the Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 4,642 4,057 4,566 4,685 4,549 4,193
Enterprise Value (EV) 1 4,642 4,057 4,566 4,685 4,549 4,193
P/E ratio 44.5 x 64.1 x 52.6 x 51.5 x 748 x 57.8 x
Yield - - - - - -
Capitalization / Revenue 2.14 x - - 2.12 x 2.59 x 2 x
EV / Revenue 2.14 x - - 2.12 x 2.59 x 2 x
EV / EBITDA - - - - - -
EV / FCF 14.6 x - - 1,015 x -50.8 x 10.4 x
FCF Yield 6.83% - - 0.1% -1.97% 9.64%
Price to Book 2.27 x - - 2.26 x - 2.15 x
Nbr of stocks (in thousands) 57,670 59,756 60,236 60,687 60,820 60,942
Reference price 2 80.50 67.90 75.80 77.20 74.80 68.80
Announcement Date 3/15/20 3/21/21 3/29/22 3/15/23 3/15/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 2,173 - - 2,211 1,756 2,098
EBITDA - - - - - -
EBIT 1 156.3 - - 131.4 -13.34 91
Operating Margin 7.19% - - 5.94% -0.76% 4.34%
Earnings before Tax (EBT) 1 134.6 - - 86.48 -31.88 91
Net income 1 106.3 62.43 87.41 91.02 6.209 72
Net margin 4.89% - - 4.12% 0.35% 3.43%
EPS 2 1.810 1.060 1.440 1.500 0.1000 1.190
Free Cash Flow 1 317.1 - - 4.617 -89.64 404
FCF margin 14.59% - - 0.21% -5.11% 19.26%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) 298.39% - - 5.07% - 561.11%
Dividend per Share - - - - - -
Announcement Date 3/15/20 3/21/21 3/29/22 3/15/23 3/15/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 564.8 596.8 480 495 533 590
EBITDA - - - - - - -
EBIT 1 - 22.33 45.2 - 13 28 50
Operating Margin - 3.95% 7.57% - 2.63% 5.25% 8.47%
Earnings before Tax (EBT) 1 - 10.17 21.49 - 13 28 50
Net income 1 39.25 10.3 27.69 - 10 22 40
Net margin - 1.82% 4.64% - 2.02% 4.13% 6.78%
EPS 2 0.6400 0.1700 0.4500 -0.0100 0.1700 0.3600 0.6600
Dividend per Share - - - - - - -
Announcement Date 8/11/22 11/10/22 3/15/23 - - - -
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 317 - - 4.62 -89.6 404
ROE (net income / shareholders' equity) 5.27% - - 4.4% 0.31% 3.72%
ROA (Net income/ Total Assets) 2.36% - - 1.91% 0.12% 1.53%
Assets 1 4,497 - - 4,773 5,140 4,706
Book Value Per Share 2 35.50 - - 34.10 - 32.00
Cash Flow per Share - - - - - -
Capex 1 88.5 - - 138 293 50
Capex / Sales 4.07% - - 6.23% 16.69% 2.38%
Announcement Date 3/15/20 3/21/21 3/29/22 3/15/23 3/15/24 -
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
68.8 TWD
Average target price
80 TWD
Spread / Average Target
+16.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
BIONIME CORPORATION Stock Bionime Corporation
-8.02% 129M
BIOMÉRIEUX Stock bioMérieux
+0.89% 12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-10.29% 7.61B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-1.16% 4.51B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+5.74% 4.49B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.70% 3.3B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+12.21% 2.73B
VITROLIFE AB Stock Vitrolife AB
-16.13% 2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-11.50% 1.73B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
-5.02% 1.64B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 4737 Stock
  4. Financials Bionime Corporation